Route choice
Womb status
Endometrial protection
Women’s Health Clinic FAQ
What is the difference between sequential (cyclical) HRT and continuous combined HRT?
HRT route and regimen choices can feel technical, but they usually come down to symptoms, womb status, bleeding pattern, risk factors and practical preference.
Direct answer
Sequential HRT usually gives progestogen for part of the cycle and may cause planned bleeding, so it is often used in perimenopause. Continuous combined HRT gives oestrogen and progestogen together continuously and is usually considered after menopause. The safest decision depends on symptoms, womb status, route, dose, medical history, personal risk factors and treatment goals. A clinician should confirm suitability, discuss alternatives and explain what needs review over time.
A good answer explains why progestogen, route, timing and review matter rather than simply listing products.
Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.
HRT options
At a glance
These are the main points to understand before deciding whether symptoms are expected, need routine review or should be assessed promptly.
At a glance
Practical clinical summary
Main area
Regimen and route
Pattern
Womb and bleeding
Watch for
Unscheduled bleeding
Next step
Tailored prescription discussion
Important safety note
If the womb is present, systemic oestrogen usually needs progestogen protection; unexpected, heavy or persistent bleeding on HRT should be reviewed.
Symptoms
Mechanism
Review
Safety
Detailed answer
Detailed answer
The key is to separate the treatment type, the symptom target and the safety question before deciding whether HRT, a local option, testosterone or a non-hormonal route is appropriate.
Sequential regimen
The reader wants regimen differences explained by menopause stage and bleeding pattern.
Pattern
Assessment
Support
Sequential regimen
Womb status is central because unopposed systemic oestrogen can stimulate the womb lining.
Continuous combined regimen
Sequential and continuous combined regimens create different bleeding expectations and review thresholds.
Bleeding expectations
Oral and transdermal routes are processed differently, which may matter for clot risk and liver-related factors.
Endometrial protection
Patches, gels, sprays, tablets or local options need to fit symptoms, preference and safety profile.
How the research shapes the answer
The research supports a shared-decision approach: symptoms matter, but so do route, dose, womb status, cancer history, clot risk, bleeding pattern and follow-up.
The benchmark guides structure and search intent; final wording avoids prescription advertising, resolved outcomes and one-size-fits-all claims.
Patient safety
Why this matters
HRT decisions can affect symptom control, bleeding expectations, sexual comfort, long-term health discussions and anxiety about risk, so the explanation needs to be precise.
Anatomy guides regimen
Womb status is central because unopposed systemic oestrogen can stimulate the womb lining.
Bleeding pattern matters
Sequential and continuous combined regimens create different bleeding expectations and review thresholds.
Route changes metabolism
Oral and transdermal routes are processed differently, which may matter for clot risk and liver-related factors.
Practical fit supports adherence
Patches, gels, sprays, tablets or local options need to fit symptoms, preference and safety profile.
A shared decision, not a script
A good HRT discussion should make the mechanism, likely benefit, uncertainty and safety boundary understandable.
The right plan may involve systemic HRT, local treatment, testosterone discussion, non-hormonal options, investigation, referral or no medicine at all.
Considerations
What to consider
A useful consultation starts with the exact symptom target, womb status, bleeding pattern, medical history, medicines, family history and the patient’s priorities.
Consultation priorities
Bring symptom timing, menstrual or bleeding history, contraception, womb status, breast or clot history, current medicines and the outcome you most want to improve.
Pattern
Options
Follow-up
Confirm womb status
Ask whether the womb is present and whether there has been hysterectomy or ovary removal.
Clarify bleeding expectations
Planned bleeding, unscheduled bleeding and postmenopausal bleeding need different interpretation.
Match route to risk
Migraine, clot risk, liver issues, preference and skin sensitivity may influence route discussion.
Review if bleeding changes
Unexpected, heavy, painful or persistent bleeding on HRT should be reviewed.
What not to assume
Do not assume HRT is automatically right, automatically unsafe, or the only route to symptom support.
Timelines and review points vary: some symptoms may change within weeks, while risk, bleeding and treatment fit need planned follow-up.
Common concerns and myths
Common misconceptions
Online menopause advice can be either dismissive or overconfident. These corrections keep the answer balanced.
Myth: All HRT regimens are the same
Reality: womb status, bleeding pattern and route can change the safest regimen and review plan.
Myth: Any bleeding on HRT is normal
Reality: womb status, bleeding pattern and route can change the safest regimen and review plan.
Myth: Progestogen is optional with a womb
Reality: womb status, bleeding pattern and route can change the safest regimen and review plan.
Precision reduces fear
Many HRT myths come from mixing different treatments, routes, risks and patient groups together.
Review keeps the plan current
Suitability can change as symptoms, age, health history, dose, route and personal priorities change.
Safety checklist
Safety checklist
Use these checks to decide whether the question can be discussed routinely or needs more prompt medical advice.
What treatment type is this?
Systemic HRT, local vaginal oestrogen, testosterone and non-hormonal medicines have different indications and safety discussions.
Is the womb present?
Womb status affects whether progestogen protection is usually needed with systemic oestrogen.
Are there risk factors?
Cancer history, clot history, liver disease, migraine, blood pressure, medicines and family history can change suitability.
Is there bleeding or urgent illness?
Unexplained bleeding, chest symptoms, stroke-like symptoms or severe allergic symptoms should not wait for routine review.
More reassuring signs
The situation is more straightforward when symptoms are stable, risks are known, bleeding has been assessed where relevant and the plan has a review point.
Improving
Reviewed
Reasons to seek advice
If the womb is present, systemic oestrogen usually needs progestogen protection; unexpected, heavy or persistent bleeding on HRT should be reviewed.
Cancer history
Chest symptoms
When to escalate
When to seek medical help
Some symptoms or history details should be assessed before starting, changing or continuing treatment.
Use NHS 111 online
Heavy or persistent bleeding
Very heavy, painful, persistent or unexplained bleeding should be assessed.
Bleeding after menopause
Bleeding after menopause should not be assumed to be a treatment side effect without review.
Clot symptoms
Chest pain, severe breathlessness or one-sided leg swelling needs urgent medical advice.
Severe side effects
Severe headache, new neurological symptoms or feeling acutely unwell needs assessment.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Additional clinical context
How to use this answer
Use the page to understand the decision point behind the HRT question, then bring symptom details, medical history and personal priorities to a clinician for shared decision-making.What to discuss at appointment
Useful details include womb status, bleeding pattern, contraception, breast history, clot history, liver or cardiovascular history, migraine, medicines, family history, symptom goals and what you would like treatment to improve.Regulatory resources
Authoritative resources
These resources support UK-facing information on HRT routes, regimens, progestogen, progesterone and endometrial protection.
NHS - Menopause treatment
UK patient baseline for HRT tablets, patches, gels and treatment routes.
NICE NG23 - Menopause: identification and management
Guideline anchor for treatment options and counselling.
British Menopause Society - Progestogens and endometrial protection
Professional resource set for progestogen, regimen and endometrial protection context.
Next step
Book a clinical consultation
A consultation can review womb status, bleeding pattern, current medicines, risk factors, route preference and the most appropriate regimen to discuss.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 12 display-ready sources, with a raw audit trail of 21 imported records. Additional reviewed material included UK clinical guidance, professional society guidance; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
